Abstract: An ink set contains: a pre-processing fluid that contains water, an aggregating agent, and a first organic solvent; a pigment ink that contains: a second organic solvent that contains water, a coloring material, and a glycolether compound; a polyoxyethylene alkyl ether; and a resin, wherein the content of the aggregating agent in the pre-processing fluid is 1.0 to 20.0 percent by mass, the content of the glycolether compound in the pigment ink is 10.0 to 20.0 percent by mass, the content of the polyoxyethylene alkyl ether therein is 1.0 to 5.0 percent by mass, the following Relationship 0.25?P/R?3.0 is satisfied, where P represents the content of the coloring material in the pigment ink and R represents the content of the resin therein, and the difference in the mixed SP value between the first and the second organic solvent is at least 2.0 (cal/cm3)0.5.

Abstract: An image forming apparatus includes a nozzle plate having two or more nozzle holes along with a piezoelectric element and an ink containing a solvent containing an organic solvent containing an alcohol-based organic solvent with a boiling point not higher than 250 degrees Celsius, wherein the average number of the two or more nozzle holes on the surface of the nozzle plate is 10 holes/mm2, and the two or more nozzle holes adjacent to each other along a direction substantially perpendicular to the conveyance direction of a recording medium is spaced 150 to 500 ?m apart.

Abstract: A primer may comprise water, a cationic resin, a polyvalent metal salt, and adiethylene glycol alkyl ether compound. A dry solid film of the primer may have a breaking energy of 20 mJ or more and 1,000 mJ or less and a breaking elongation of 500% or more and 2,500% or less, which are measured by a tensile tester having a tensile speed of 150 mm/min.

Abstract: A primer is provided that includes water, a cationic resin, a polyvalent metal salt, and a diethylene glycol alkyl ether-based organic solvent.

Abstract: A urea removing apparatus has: a determining section that determines whether or not a urea aqueous solution is injected from an injection nozzle when control is performed to inject the urea aqueous solution from the injection nozzle into an exhaust pipe where exhaust gas of an engine flows; a supply control section that controls a pump that supplies the urea aqueous solution to the injection nozzle from a tank that stores the urea aqueous solution, and causes the urea aqueous solution to be supplied from the tank to the injection nozzle in a case that it is determined that the urea aqueous solution is not injected from the injection nozzle; and a temperature control section that performs control to raise the temperature of exhaust gas in a state where the urea aqueous solution supplied from the tank has been poured into the injection nozzle.

Abstract: A urea removing apparatus has: a determining section that determines whether or not a urea aqueous solution is injected from an injection nozzle when control is performed to inject the urea aqueous solution from the injection nozzle into an exhaust pipe where exhaust gas of an engine flows; a supply control section that controls a pump that supplies the urea aqueous solution to the injection nozzle from a tank that stores the urea aqueous solution, and causes the urea aqueous solution to be supplied from the tank to the injection nozzle in a case that it is determined that the urea aqueous solution is not injected from the injection nozzle; and a temperature control section that performs control to raise the temperature of exhaust gas in a state where the urea aqueous solution supplied from the tank has been poured into the injection nozzle.

Abstract: An active energy ray curing composition contains a polymerizable monomer having a phosphoric acid ester group and a polyester resin having an unsaturated bond and a number average molecular weight of 3,000 or less.

Abstract: An active energy ray curing composition contains a urethane acrylate oligomer (A) having three or more polymerizable functional groups, a polyfunctional monomer (B) having three or more polymerizable functional groups, a monofunctional monomer (C), and a surfactant (D) having a siloxane bond, wherein the urethane acrylate oligomer (A) has a glass transition temperature of 85 degrees C. or lower, wherein the urethane acrylate oligomer (A) has a weight average molecular weight of from 1,000 to 9,000, wherein the polyfunctional monomer (B) accounts for 22.0 to 60.0 percent by mass of the entire of the active energy ray curing composition.

Abstract: An image forming method is provided that includes: applying, on a base, an active energy ray-curable composition A containing a polymerizable monomer having a phosphoric ester group and a polyester resin; curing the active energy ray-curable composition A; applying, on a cured object of the active energy ray-curable composition A, an active energy ray-curable composition B containing a multifunctional polymerizable compound having two or more polymerizable functional groups in its molecule; and curing the active energy ray-curable composition B.

Abstract: An active-energy-ray-curable composition includes: an adduct of trifunctional urethane acrylate; and a heterocyclic monofunctional monomer. A proportion of the heterocyclic monofunctional monomer in the active-energy-ray-curable composition is 10% by mass or more but 60% by mass or less.

Abstract: A detection method of detecting CTCs as target cells contained in a test sample, the method includes a concentration step of concentrating the target cells contained in the test sample, a labeling step of labeling the target cells and other components by bringing the concentrated test sample into contact with first labeling antibodies in which antibodies specifically binding to antigens, which exclude antigens expressing in epithelial cells and specifically express in the target cells, are labeled by a first labeling substance, and into contact with second labeling antibodies in which antibodies binding to antigens expressing in the other components excluding the target cells are labeled by a second labeling substance, and a detection step of detecting, from the test sample, cells that are labeled by the first labeling antibodies and are not labeled by the second labeling antibodies as the target cells.

Abstract: A vascular aging inhibitor includes a low molecular weight collagen derived from fish skin as an essential component, wherein the weight average molecular weight of the low molecular weight collagen derived from fish skin is approximately 3,000.

Abstract: A medical insurance system wherein disclosure of preexisting conditions is appropriately performed upon the creation of an insurance contract. A party wishing to purchase insurance from an insurance company 10 agrees that personal medical data obtained from a database 16 of a medical facility 14, possibly including data from a physical examination conducted at the medical facility 14 or a prior diagnosis of illness, is stored in a database 12 of the insurance company 10. The parties agree that in this manner disclosure of preexisting conditions is regarded as being complete. Disclosure of preexisting conditions is easily and accurately performed.

Abstract: A taping supporter of the invention is worn around a joint and a surrounding portion of a user for tightly support the same. The taping supporter is formed of a cylindrical body having a size slightly smaller than a size of the joint and the surrounding portion to be worn. The cylindrical body is made of a resilient material to tightly hold and support the joint and the surrounding portion. Signs or wrapping marks are printed on the outer surface of the cylindrical body to apply tapes thereon along the signs. When used, the cylindrical body is worn and the tapes are applied along the signs. Consequently, the joint and the surrounding portion are well supported by the cylindrical body and the tapes.